Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

Published:2014-07-10 Issue:2 Volume:22 Page:175-183
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Cortesi P. A.¹,Ciaccio A.²,Rota M.³,Lim J. K.⁴,De Salvia S.²,Okolicsanyi S.²,Vinci M.⁵,Belli L. S.⁵,Mantovani L. G.⁶,Strazzabosco M.²⁴

Affiliation:

1. Research Centre on Public Health (CESP); University of Milan-Bicocca; Monza Italy

2. Department of Surgical and Interdisciplinary Medicine; University of Milan-Bicocca; Monza Italy

3. Department of Health Sciences; Centre of Biostatistics for Clinical Epidemiology; University of Milan-Bicocca; Monza Italy

4. Liver Center & Section of Digestive Diseases; Department of Internal Medicine; Yale University School of Medicine; New Haven CT USA

5. Department of Hepatology and Liver Unit; Niguarda Hospital; Milan Italy

6. Department of Clinical Medicine and Surgery; University Federico II of Naples; Naples Italy

Funder

NIH

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12278/fullpdf

Reference31 articles.

1. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups;Poynard;Lancet,1997

2. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients;Fattovich;Gastroenterology,1997

3. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study;Bruno;Hepatology,2007

4. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection;McHutchison;N Engl J Med,2009

5. Boceprevir for untreated chronic HCV genotype 1 infection;Poordad;N Engl J Med,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health Related Quality of Life norm data of the Italian general population: results using the EQ-5D-3L and EQ-5D-5L instruments;Epidemiology, Biostatistics, and Public Health;2022-05-06

2. Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis;Liver International;2021-03-18

3. The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries;Liver International;2021-02-24

4. Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results;Applied Health Economics and Health Policy;2020-07-14

5. Systematic review of health state utility values used in pharmacoeconomic evaluations for chronic hepatitis C: impact on cost-effectiveness results;2020-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3